Vyvgart
Vyvgart ingredients
| Active ingredient | Strength |
|---|---|
| Efgartigimod Alfa | 20 mg/mL |
What Vyvgart is used for
The FDA lists the approved uses on the official label (below). In the EU, efgartigimod alfa is approved as Vyvgart for:
Vyvgart is indicated as- an add-on to standard therapy for the treatment of adult patients with generalised Myasthenia Gravis (gMG) who are antiacetylcholine receptor (AChR) antibody positive.- monotherapy for the treatment of adult patients with progressive or relapsing active chronic inflammatory demyelinating polyneuropathy (CIDP) after prior treatment with corticosteroids or immunoglobulins.
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Vyvgart
- Generic name
- Efgartigimod alfa
- Made by
- argenx US
- Forms
- Injection
- Given
- Intravenous
- Drug class
- Neonatal Fc Receptor Blocker
- FDA approval
- Biologic licence (BLA) BLA761195
- On the US market since
- 2021
Official information
- Vyvgart prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Efgartigimod alfa)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Vyvgart?
Vyvgart (Efgartigimod alfa) is a specialist medicine made by argenx US, approved by the US FDA.
What are the ingredients of Vyvgart?
Vyvgart contains Efgartigimod Alfa (20 mg/mL).
Is Vyvgart approved in Europe?
The same active substance is approved in the EU as Vyvgart.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA